Fulgent Genetics, Inc. (FLGT) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts FLGT Hot Sheet
Join SI Premium – FREE
Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q2 EPS of $0.78, $0.05 better than the analyst estimate of $0.73. Revenue for the quarter came in at $125.3 million versus the consensus estimate of $122.7 million.
GUIDANCE:
Fulgent Genetics, Inc. sees Q3 2022 revenue of $105 million, versus the consensus of $106.3 million.
Fulgent Genetics, Inc. sees FY2022 EPS of $6.00, versus the consensus of $6.23. Fulgent Genetics, Inc. sees FY2022 revenue of $665 million, versus the consensus of $649.6 million.
For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- SoFi Technologies (SOFI) Tops Q3 EPS by 1c, Offers Guidance
- Baldwin Group posts 31% revenue gain, reports pending go-private deal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
